Prostate Cancer - Results from #140

Isolation and Characterization of Urinary Extracellular Vesicles from Healthy Donors and Patients with Castration-Resistant Prostate Cancer. July 12, 2022

Clinical use of the mRNA urinary biomarker SelectMDx test for prostate cancer. July 12, 2022

GEOGRAPHIC VARIATION OF INFECTIOUS COMPLICATIONS FOLLOWING PROSTATE BIOPSY IN THE UNITED STATES: RESULTS FROM A POPULATION-BASED COHORT OF PRIVATELY INSURED PATIENTS. July 12, 2022

Role of Deep Learning in Prostate Cancer Management: Past, Present and Future Based on a Comprehensive Literature Review. July 12, 2022

Incidence, Mortality, and Trends of Prostate Cancer in Mexico from 2000 to 2019: Results from the Global Burden of Disease Study 2019. July 12, 2022

Modifiable risk factors for prostate cancer in low- and lower-middle-income countries: a systematic review and meta-analysis. July 11, 2022

Cardiovascular disease prevention and management of pre-existent cardiovascular disease in a cohort of prostate cancer survivors. July 11, 2022

Schema and cancer detection rates for transperineal prostate biopsy templates: a review. July 11, 2022

Systematic review of the impact of a plant-based diet on prostate cancer incidence and outcomes. July 11, 2022

The future of PSMA PET and WB MRI as next-generation imaging tools in prostate cancer. July 11, 2022

Development and validation of a multivariable prognostic model in de novo metastatic castrate sensitive prostate cancer. July 8, 2022

Toxicity and outcomes after external beam irradiation for prostate cancer in patients with prior holmium laser enucleation of the prostate: Early experience. July 8, 2022

Image-guided in-Vivo Needle-Based Confocal Laser Endomicroscopy in the Prostate: Safety and Feasibility Study in 2 Patients. July 8, 2022

The impact of 3D models on positive surgical margins after robot-assisted radical prostatectomy. July 8, 2022

A novel prognostic model predicting overall survival in patients with metastatic castration-resistant prostate cancer receiving standard chemotherapy: A multi-trial cohort analysis. July 8, 2022

Racial differences in circulating mitochondria-derived peptides may contribute to prostate cancer health disparities. July 7, 2022

Pre- and intratherapeutic predictors of overall survival in patients with advanced metastasized castration-resistant prostate cancer receiving Lu-177-PSMA-617 radioligand therapy. July 7, 2022

A Phase II prospective study of hypofractionated proton therapy of prostate and pelvic lymph nodes: Acute effects on patient-reported quality of life. July 7, 2022

The Clinical Significance of Maximum Tumor Diameter on MRI in Men Undergoing Radical Prostatectomy or Definitive Radiotherapy for Locoregional Prostate Cancer. July 7, 2022

The impact of health-policy-driven subsidisation of prostate magnetic resonance imaging on transperineal prostate biopsy practice and outcomes. July 7, 2022

Page 8 of 1241

email news signup